TC Medical(SH:600763) Sou Hu Cai Jing·2025-11-13 11:43Core Viewpoint - Tongce Medical (600763) shows a slight increase in stock price and mixed capital flow, indicating potential investor interest and market dynamics [1][2]. Group 1: Stock Performance - As of November 13, 2025, Tongce Medical's stock closed at 44.75 yuan, up 0.36% with a turnover rate of 1.51% and a trading volume of 67,500 hands, resulting in a transaction amount of 301 million yuan [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with a net outflow of 38.44 million yuan from main funds on November 13, accounting for 12.79% of the total transaction amount [2]. Group 2: Financial Metrics - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit attributable to shareholders of 514 million yuan, up 3.16% year-on-year [3]. - The company's third-quarter performance included a single-quarter main revenue of 842 million yuan, reflecting a 2.34% year-on-year increase, and a net profit of 192 million yuan, up 2.31% year-on-year [3]. Group 3: Industry Comparison - Tongce Medical's total market value stands at 20.016 billion yuan, slightly above the industry average of 19.945 billion yuan, ranking 8th in the industry [3]. - The company has a net profit margin of 26.91%, significantly higher than the industry average of 4.43%, ranking 3rd in the industry [3]. Group 4: Analyst Ratings - In the last 90 days, 11 institutions have rated Tongce Medical, with 8 buy ratings and 3 hold ratings, indicating a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 51.78 yuan, suggesting potential upside from the current trading price [4].